equityflowunderstand the flow and follow it
EquityFlow › Companies › Shift Bioscience

Shift Bioscience

Biotech · Cambridge, GB

Biotech using generative AI to study and reverse cellular aging.

In the network

Shares the most investors with (number = shared investors):
Puraffinity 2

Funding history

DateRoundAmount
Oct 2024Seed
Shift Bioscience, a Cambridge aging-research biotech, raised a GBP12.5M (about $16M) seed led by BGF.
$16M

Investors

Tap an investor to see what else they have backed.

BGFF-Prime CapitalKindred Capital

Other companies in Biotech

ImperagenHaga BiosciencePixelgen TechnologiesGallantChai DiscoverySNIPR BiomeCellbox LabsScope BiosciencesGenLuminaActitheraNUCLIDIUMAnocca

Other companies in GB

Capsa AI01HealthRem3dy HealthNewOrbitJoyvié HealthFuse EnergyAirspeedSembleWordsmithOxford Quantum CircuitsFreshaImperagen

Other companies at Seed stage

&Open(Re)vive1-2-Taste100% Livre1000 Satellites100ms10club10pct.10x Science10x.team123Projetei150 Minuten
Explore funding flow on EquityFlow →

Data is community-curated and may be incomplete.